Comparison of the polymer-free biolimus-coated BioFreedom stent with the thin strut biodegradable polymer sirolimus-eluting Orsiro stent in an all-comers population treated with percutaneous coronary intervention: Rationale and design of the randomized SORT OUT IX trial

ConclusionThe SORT OUT IX trial will determine whether the drug-coated BioFreedom stent is non-inferior to a modern biodegradable polymer Orsiro stent.
Source: American Heart Journal - Category: Cardiology Source Type: research